Global Oligonucleotide API Market Research Report 2023

Publication ID:

PB503235307

Publication Date:

March 10, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Specialty Chemicals [2]

Manufacturing (Chemicals) [3]

Chemicals [4]

Description:

The global Oligonucleotide API market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Oligonucleotide API is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Oligonucleotide API is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Oligonucleotide API include Jazz Pharmaceuticals, Sarepta Therapeutics, Biogen, Dynavax Technologies, Akcea Therapeutics, Alnylam Pharmaceuticals, Nitto Denko (Avecia), Ajinomoto (GeneDesign) and RiboBio, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Oligonucleotide API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oligonucleotide API.
The Oligonucleotide API market size, estimations, and forecasts are provided in terms of output/shipments (Ton) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Oligonucleotide API market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oligonucleotide API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Jazz Pharmaceuticals
Sarepta Therapeutics
Biogen
Dynavax Technologies
Akcea Therapeutics
Alnylam Pharmaceuticals
Nitto Denko (Avecia)
Ajinomoto (GeneDesign)
RiboBio
Segment by Type
Antisense Oligonucleotides API
Small Interfering RNA (siRNA) API
MiRNA API
CpG Oligonucleotides API
Others
Segment by Application
Contract Manufacturing Organizations (CMOs)
Pharmaceutical Companies
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by type, by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Oligonucleotide API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Oligonucleotide API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Oligonucleotide API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Oligonucleotide API Market Overview
1.1 Product Definition
1.2 Oligonucleotide API Segment by Type
1.2.1 Global Oligonucleotide API Market Value Growth Rate Analysis by Type 2022 VS 2029
1.2.2 Antisense Oligonucleotides API
1.2.3 Small Interfering RNA (siRNA) API
1.2.4 MiRNA API
1.2.5 CpG Oligonucleotides API
1.2.6 Others
1.3 Oligonucleotide API Segment by Application
1.3.1 Global Oligonucleotide API Market Value Growth Rate Analysis by Application: 2022 VS 2029
1.3.2 Contract Manufacturing Organizations (CMOs)
1.3.3 Pharmaceutical Companies
1.4 Global Market Growth Prospects
1.4.1 Global Oligonucleotide API Production Value Estimates and Forecasts (2018-2029)
1.4.2 Global Oligonucleotide API Production Capacity Estimates and Forecasts (2018-2029)
1.4.3 Global Oligonucleotide API Production Estimates and Forecasts (2018-2029)
1.4.4 Global Oligonucleotide API Market Average Price Estimates and Forecasts (2018-2029)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Oligonucleotide API Production Market Share by Manufacturers (2018-2023)
2.2 Global Oligonucleotide API Production Value Market Share by Manufacturers (2018-2023)
2.3 Global Key Players of Oligonucleotide API, Industry Ranking, 2021 VS 2022 VS 2023
2.4 Global Oligonucleotide API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Oligonucleotide API Average Price by Manufacturers (2018-2023)
2.6 Global Key Manufacturers of Oligonucleotide API, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Oligonucleotide API, Product Offered and Application
2.8 Global Key Manufacturers of Oligonucleotide API, Date of Enter into This Industry
2.9 Oligonucleotide API Market Competitive Situation and Trends
2.9.1 Oligonucleotide API Market Concentration Rate
2.9.2 Global 5 and 10 Largest Oligonucleotide API Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Oligonucleotide API Production by Region
3.1 Global Oligonucleotide API Production Value Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.2 Global Oligonucleotide API Production Value by Region (2018-2029)
3.2.1 Global Oligonucleotide API Production Value Market Share by Region (2018-2023)
3.2.2 Global Forecasted Production Value of Oligonucleotide API by Region (2024-2029)
3.3 Global Oligonucleotide API Production Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.4 Global Oligonucleotide API Production by Region (2018-2029)
3.4.1 Global Oligonucleotide API Production Market Share by Region (2018-2023)
3.4.2 Global Forecasted Production of Oligonucleotide API by Region (2024-2029)
3.5 Global Oligonucleotide API Market Price Analysis by Region (2018-2023)
3.6 Global Oligonucleotide API Production and Value, Year-over-Year Growth
3.6.1 North America Oligonucleotide API Production Value Estimates and Forecasts (2018-2029)
3.6.2 Europe Oligonucleotide API Production Value Estimates and Forecasts (2018-2029)
3.6.3 China Oligonucleotide API Production Value Estimates and Forecasts (2018-2029)
3.6.4 Japan Oligonucleotide API Production Value Estimates and Forecasts (2018-2029)
4 Oligonucleotide API Consumption by Region
4.1 Global Oligonucleotide API Consumption Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
4.2 Global Oligonucleotide API Consumption by Region (2018-2029)
4.2.1 Global Oligonucleotide API Consumption by Region (2018-2023)
4.2.2 Global Oligonucleotide API Forecasted Consumption by Region (2024-2029)
4.3 North America
4.3.1 North America Oligonucleotide API Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.3.2 North America Oligonucleotide API Consumption by Country (2018-2029)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Oligonucleotide API Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.4.2 Europe Oligonucleotide API Consumption by Country (2018-2029)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Oligonucleotide API Consumption Growth Rate by Region: 2018 VS 2022 VS 2029
4.5.2 Asia Pacific Oligonucleotide API Consumption by Region (2018-2029)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Oligonucleotide API Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.6.2 Latin America, Middle East & Africa Oligonucleotide API Consumption by Country (2018-2029)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Oligonucleotide API Production by Type (2018-2029)
5.1.1 Global Oligonucleotide API Production by Type (2018-2023)
5.1.2 Global Oligonucleotide API Production by Type (2024-2029)
5.1.3 Global Oligonucleotide API Production Market Share by Type (2018-2029)
5.2 Global Oligonucleotide API Production Value by Type (2018-2029)
5.2.1 Global Oligonucleotide API Production Value by Type (2018-2023)
5.2.2 Global Oligonucleotide API Production Value by Type (2024-2029)
5.2.3 Global Oligonucleotide API Production Value Market Share by Type (2018-2029)
5.3 Global Oligonucleotide API Price by Type (2018-2029)
6 Segment by Application
6.1 Global Oligonucleotide API Production by Application (2018-2029)
6.1.1 Global Oligonucleotide API Production by Application (2018-2023)
6.1.2 Global Oligonucleotide API Production by Application (2024-2029)
6.1.3 Global Oligonucleotide API Production Market Share by Application (2018-2029)
6.2 Global Oligonucleotide API Production Value by Application (2018-2029)
6.2.1 Global Oligonucleotide API Production Value by Application (2018-2023)
6.2.2 Global Oligonucleotide API Production Value by Application (2024-2029)
6.2.3 Global Oligonucleotide API Production Value Market Share by Application (2018-2029)
6.3 Global Oligonucleotide API Price by Application (2018-2029)
7 Key Companies Profiled
7.1 Jazz Pharmaceuticals
7.1.1 Jazz Pharmaceuticals Oligonucleotide API Corporation Information
7.1.2 Jazz Pharmaceuticals Oligonucleotide API Product Portfolio
7.1.3 Jazz Pharmaceuticals Oligonucleotide API Production, Value, Price and Gross Margin (2018-2023)
7.1.4 Jazz Pharmaceuticals Main Business and Markets Served
7.1.5 Jazz Pharmaceuticals Recent Developments/Updates
7.2 Sarepta Therapeutics
7.2.1 Sarepta Therapeutics Oligonucleotide API Corporation Information
7.2.2 Sarepta Therapeutics Oligonucleotide API Product Portfolio
7.2.3 Sarepta Therapeutics Oligonucleotide API Production, Value, Price and Gross Margin (2018-2023)
7.2.4 Sarepta Therapeutics Main Business and Markets Served
7.2.5 Sarepta Therapeutics Recent Developments/Updates
7.3 Biogen
7.3.1 Biogen Oligonucleotide API Corporation Information
7.3.2 Biogen Oligonucleotide API Product Portfolio
7.3.3 Biogen Oligonucleotide API Production, Value, Price and Gross Margin (2018-2023)
7.3.4 Biogen Main Business and Markets Served
7.3.5 Biogen Recent Developments/Updates
7.4 Dynavax Technologies
7.4.1 Dynavax Technologies Oligonucleotide API Corporation Information
7.4.2 Dynavax Technologies Oligonucleotide API Product Portfolio
7.4.3 Dynavax Technologies Oligonucleotide API Production, Value, Price and Gross Margin (2018-2023)
7.4.4 Dynavax Technologies Main Business and Markets Served
7.4.5 Dynavax Technologies Recent Developments/Updates
7.5 Akcea Therapeutics
7.5.1 Akcea Therapeutics Oligonucleotide API Corporation Information
7.5.2 Akcea Therapeutics Oligonucleotide API Product Portfolio
7.5.3 Akcea Therapeutics Oligonucleotide API Production, Value, Price and Gross Margin (2018-2023)
7.5.4 Akcea Therapeutics Main Business and Markets Served
7.5.5 Akcea Therapeutics Recent Developments/Updates
7.6 Alnylam Pharmaceuticals
7.6.1 Alnylam Pharmaceuticals Oligonucleotide API Corporation Information
7.6.2 Alnylam Pharmaceuticals Oligonucleotide API Product Portfolio
7.6.3 Alnylam Pharmaceuticals Oligonucleotide API Production, Value, Price and Gross Margin (2018-2023)
7.6.4 Alnylam Pharmaceuticals Main Business and Markets Served
7.6.5 Alnylam Pharmaceuticals Recent Developments/Updates
7.7 Nitto Denko (Avecia)
7.7.1 Nitto Denko (Avecia) Oligonucleotide API Corporation Information
7.7.2 Nitto Denko (Avecia) Oligonucleotide API Product Portfolio
7.7.3 Nitto Denko (Avecia) Oligonucleotide API Production, Value, Price and Gross Margin (2018-2023)
7.7.4 Nitto Denko (Avecia) Main Business and Markets Served
7.7.5 Nitto Denko (Avecia) Recent Developments/Updates
7.8 Ajinomoto (GeneDesign)
7.8.1 Ajinomoto (GeneDesign) Oligonucleotide API Corporation Information
7.8.2 Ajinomoto (GeneDesign) Oligonucleotide API Product Portfolio
7.8.3 Ajinomoto (GeneDesign) Oligonucleotide API Production, Value, Price and Gross Margin (2018-2023)
7.8.4 Ajinomoto (GeneDesign) Main Business and Markets Served
7.7.5 Ajinomoto (GeneDesign) Recent Developments/Updates
7.9 RiboBio
7.9.1 RiboBio Oligonucleotide API Corporation Information
7.9.2 RiboBio Oligonucleotide API Product Portfolio
7.9.3 RiboBio Oligonucleotide API Production, Value, Price and Gross Margin (2018-2023)
7.9.4 RiboBio Main Business and Markets Served
7.9.5 RiboBio Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Oligonucleotide API Industry Chain Analysis
8.2 Oligonucleotide API Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Oligonucleotide API Production Mode & Process
8.4 Oligonucleotide API Sales and Marketing
8.4.1 Oligonucleotide API Sales Channels
8.4.2 Oligonucleotide API Distributors
8.5 Oligonucleotide API Customers
9 Oligonucleotide API Market Dynamics
9.1 Oligonucleotide API Industry Trends
9.2 Oligonucleotide API Market Drivers
9.3 Oligonucleotide API Market Challenges
9.4 Oligonucleotide API Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer

Companies Mentioned:

Jazz Pharmaceuticals
Sarepta Therapeutics
Biogen
Dynavax Technologies
Akcea Therapeutics
Alnylam Pharmaceuticals
Nitto Denko (Avecia)
Ajinomoto (GeneDesign)
RiboBio

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂